The Heparin-Antithrombin Product: A Novel Value for Pediatric Extracorporeal Anticoagulation
- PMID: 35928336
- PMCID: PMC9302401
- DOI: 10.1182/ject-115-122
The Heparin-Antithrombin Product: A Novel Value for Pediatric Extracorporeal Anticoagulation
Abstract
Hematologic complications are a source of morbidity and mortality for patients receiving extracorporeal membrane oxygenation (ECMO) support. There is no consensus strategy for monitoring anticoagulation for children supported with ECMO. This study evaluated a novel measurement of anticoagulation for children on ECMO. This was a single-center observational study of children supported with ECMO from 2015 to 2020. Each patient's current unfractionated heparin dose was multiplied by the current antithrombin III (AT) level to obtain a novel anticoagulation value, the heparin-antithrombin product (HAP). This value was compared with the heparin dose, AT, and activated clotting time (ACT) to predict anti-Xa value using linear correlation and decision tree methods. Data were obtained from 128 patients supported with ECMO. The HAP value was more highly correlated with anti-Xa level than heparin dose, AT level, and ACT. This correlation was highest in the neonatal population (r = .7). The variable importance metrics from the regression tree and random forest models both identified the HAP value as the most influential predictor variable for anti-Xa value. The HAP value is more highly correlated with the anti-Xa level than heparin dose, AT level, or ACT. Further research is needed to evaluate the effectiveness of the HAP value as a measurement of anticoagulation for children on ECMO.
Keywords: anticoagulation; critical care medicine.; extracorporeal membrane oxygenation; pediatrics.
© Copyright 2022 AMSECT.
Figures
References
-
- Hirsh J, Anand SS, Halperin JL, et al. . Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol. 2001;21:1094–6. - PubMed
-
- Extracorporeal Life Support Organization . ELSO Anticoagulation Guidelines. 2014. [cited 2021 June 28]. Available at: https://www.elso.org/Portals/0/Files/elsoanticoagulationguideline8-2014-.... Accessed June 12, 2021.
-
- Padhya DR, Prutsky GJ, Nemergut ME, et al. . Routine laboratory measures of heparin anticoagulation for children on extracorporeal membrane oxygenation: Systematic review and meta-analysis. Thromb Res. 2019;179:132–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical